Jane Street’s Silence Therapeutics SLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$646K Buy
+59,100
New +$719K ﹤0.01% 7428

Other funds holding SLN

Jane Street's SLN Position: Q3 2026 in Review

Jane Street reduced its Silence Therapeutics (SLN) stake by 48% in Q3 2026, selling an estimated $2.15M and leaving 192,595 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #5061.

Jane Street first reported a position in SLN in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.05M in Q2 2026. 92 funds tracked by Wall St. Rank hold SLN as of Q3 2026.

  • Jane Street held 192,595 shares of Silence Therapeutics worth $2.11M as of Q3 2026.
  • Jane Street sold 176,556 Silence Therapeutics shares in Q3 2026, an estimated $2.15M.
  • Silence Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #5061 holding.
  • Jane Street first reported a position in Silence Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Jane Street's Silence Therapeutics position peaked at $4.05M in Q2 2026.
  • 92 funds tracked by Wall St. Rank held Silence Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.